Similarly to Iba1, CD11b and CD45 showed no differences between genotypes at any timepoint (Figures 5c,d), thus supporting no differences in microgliosis and no effect of Gal3 toward these receptors in the context of AD. This evidence concerns the gene ITGAM and Alzheimer disease.